The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6138019 6888847 F 6138019-5 20080807 20090324 20090331 EXP JP-BAYER-200910129BYL BAYER HEALTHCARE PHARMACEUTICALS INC. 69 YR M Y 67 KG 20090331 MD 20081228 JAPAN

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6138019 1011355916 PS NEXAVAR 1 ORAL TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG 021923
6138019 1011355917 C TAGAMET 1 ORAL UNIT DOSE: 200 MG
6138019 1011355918 C MOBIC 1 ORAL TOTAL DAILY DOSE: 10 MG UNIT DOSE: 10 MG

Indications of drugs used

Event ID DRUG SEQ INDI PT
6138019 1011355916 RENAL CELL CARCINOMA STAGE IV

Outcome of event

Event ID OUTC COD
6138019 DE
6138019 HO

Reactions reported

Event ID PT
6138019 HEPATIC FUNCTION ABNORMAL
6138019 ILEUS
6138019 MALIGNANT PLEURAL EFFUSION

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6138019 1011355916 20080523 20081104 120 DAY
6138019 1011355917 20080108 20081201 11 MON
6138019 1011355918 20080108 20081201 11 MON